Brief: NextCell Pharma: Discussions On Merger Between Nextcell And Idogen Suspended

NextCell Pharma AB

08/05/2019 07:13

May 8 (Reuters) - NextCell Pharma Ab  NXTCL.TE :
    * DISCUSSIONS ON A MERGER BETWEEN NEXTCELL AB AND IDOGEN AB
ARE
SUSPENDED
    * BOARDS OF COMPANIES HAVE CONCLUDED THAT BOTH COMPANIES
WILL
BENEFIT FROM CONTINUING TO PURSUE THEIR OWN ACTIVITIES.
    * COMPANIES CHOOSE TO CONTINUE DISCUSSIONS ON HOW COMPANIES
COULD
FURTHER COOPERATE IN FUTURE.
    * "PERHAPS WE MAY FIND OTHER MEANS TO COLLABORATE,"
    * " WE WERE UNABLE TO CREATE A STRUCTURE THAT WAS
SATISFACTORY FOR
BOTH PARTIES"

Source text for Eikon:  ID:nWkr4h99f8 
Further company coverage:  NXTCL.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))